开云app官网登录入口网页版-官方正版

#载体#

116篇内容 | 2248人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1645512, encodeId=375316455123e, content=<a href='/topic/show?id=db329364360' target=_blank style='color:#2F92EE;'>#载体#</a>, objectTitle=Nat Biotech：一次生产10亿CAR-T细胞，新型CRISPR技术，无需病毒载体高效插入超长DNA序列, objectType=article, longId=739036, objectId=f1d8e3903613, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1d8e3903613, replyNumber=0, likeNumber=132, createdTime=2023-05-20, rootId=0, userName=mei539, userId=58cb23213384, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1d8e3903613, moduleTitle=Nat Biotech：一次生产10亿CAR-T细胞，新型CRISPR技术，无需病毒载体高效插入超长DNA序列, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=f1d8e3903613)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645510, encodeId=9259164551069, content=<a href='/topic/show?id=db329364360' target=_blank style='color:#2F92EE;'>#载体#</a>, objectTitle=Arch Dermatol Res：负载维甲酸的纳米脂质载体可有效且安全的治疗寻常痤疮 , objectType=article, longId=733184, objectId=480ae33184aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=480ae33184aa, replyNumber=0, likeNumber=0, createdTime=2022-11-26, rootId=0, userName=mei539, userId=58cb23213384, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=480ae33184aa, moduleTitle=Arch Dermatol Res：负载维甲酸的纳米脂质载体可有效且安全的治疗寻常痤疮 , moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=480ae33184aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645506, encodeId=68b21645506da, content=<a href='/topic/show?id=db329364360' target=_blank style='color:#2F92EE;'>#载体#</a>, objectTitle=STTT：治愈乙肝新希望：新型纳米载体，递送siRNA特异性靶向肝细胞, objectType=article, longId=299378, objectId=64612993e804, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64612993e804, replyNumber=0, likeNumber=88, createdTime=2022-11-16, rootId=0, userName=mei539, userId=58cb23213384, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64612993e804, moduleTitle=STTT：治愈乙肝新希望：新型纳米载体，递送siRNA特异性靶向肝细胞, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=64612993e804)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645509, encodeId=019f164550927, content=<a href='/topic/show?id=db329364360' target=_blank style='color:#2F92EE;'>#载体#</a>, objectTitle=Nature Biomedical Engineering：中科大朱书/王育才团队合作开发新型口服抗生素递送载体，促进吸收，且保护肠道菌群稳态, objectType=article, longId=731906, objectId=c495e31906a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c495e31906a7, replyNumber=0, likeNumber=88, createdTime=2022-08-28, rootId=0, userName=mei539, userId=58cb23213384, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c495e31906a7, moduleTitle=Nature Biomedical Engineering：中科大朱书/王育才团队合作开发新型口服抗生素递送载体，促进吸收，且保护肠道菌群稳态, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c495e31906a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645511, encodeId=0d181645511dd, content=<a href='/topic/show?id=db329364360' target=_blank style='color:#2F92EE;'>#载体#</a>, objectTitle=高效促进吸收！研究开发出新型口服抗生素递送载体, objectType=article, longId=732050, objectId=72dbe32050f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72dbe32050f8, replyNumber=0, likeNumber=89, createdTime=2022-12-22, rootId=0, userName=mei539, userId=58cb23213384, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72dbe32050f8, moduleTitle=高效促进吸收！研究开发出新型口服抗生素递送载体, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=72dbe32050f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645505, encodeId=75b6164550522, content=<a href='/topic/show?id=db329364360' target=_blank style='color:#2F92EE;'>#载体#</a>, objectTitle=Cell重磅：刘如谦开发新型类病毒载体，安全高效进行体内基因编辑, objectType=article, longId=294244, objectId=ee7129424476, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee7129424476, replyNumber=0, likeNumber=74, createdTime=2022-06-17, rootId=0, userName=mei539, userId=58cb23213384, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee7129424476, moduleTitle=Cell重磅：刘如谦开发新型类病毒载体，安全高效进行体内基因编辑, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ee7129424476)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645508, encodeId=f835164550850, content=<a href='/topic/show?id=db329364360' target=_blank style='color:#2F92EE;'>#载体#</a>, objectTitle=突发！强生腺病毒载体新冠疫苗因血栓风险，被FDA限制授权使用, objectType=article, longId=726293, objectId=2a50e26293e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a50e26293e8, replyNumber=0, likeNumber=78, createdTime=2022-06-28, rootId=0, userName=mei539, userId=58cb23213384, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a50e26293e8, moduleTitle=突发！强生腺病毒载体新冠疫苗因血栓风险，被FDA限制授权使用, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2a50e26293e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645507, encodeId=da4f164550e3a, content=<a href='/topic/show?id=db329364360' target=_blank style='color:#2F92EE;'>#载体#</a>, objectTitle=秋水仙碱可能会干扰基于腺病毒载体的 COVID-19 疫苗的功效, objectType=article, longId=302289, objectId=057330228912, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=057330228912, replyNumber=0, likeNumber=145, createdTime=2022-11-10, rootId=0, userName=mei539, userId=58cb23213384, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=057330228912, moduleTitle=秋水仙碱可能会干扰基于腺病毒载体的 COVID-19 疫苗的功效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=057330228912)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645500, encodeId=6f8916455007b, content=<a href='/topic/show?id=db329364360' target=_blank style='color:#2F92EE;'>#载体#</a>, objectTitle=病毒载体基因治疗CDMO引领者五加和基因完成A轮融资，凯乘资本担任独家财务顾问 , objectType=article, longId=217846, objectId=302321e84652, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=302321e84652, replyNumber=0, likeNumber=84, createdTime=2022-01-14, rootId=0, userName=mei539, userId=58cb23213384, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=302321e84652, moduleTitle=病毒载体基因治疗CDMO引领者五加和基因完成A轮融资，凯乘资本担任独家财务顾问 , moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=302321e84652)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645502, encodeId=f7bd164550228, content=<a href='/topic/show?id=db329364360' target=_blank style='color:#2F92EE;'>#载体#</a>, objectTitle=HAEMATOLOGICA：离子载体介导的红细胞渗透肿胀是镰状细胞病治疗的潜在机制, objectType=article, longId=219576, objectId=4e612195e65e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e612195e65e, replyNumber=0, likeNumber=98, createdTime=2022-03-13, rootId=0, userName=mei539, userId=58cb23213384, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e612195e65e, moduleTitle=HAEMATOLOGICA：离子载体介导的红细胞渗透肿胀是镰状细胞病治疗的潜在机制, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=4e612195e65e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645499, encodeId=4af51645499c3, content=<a href='/topic/show?id=db329364360' target=_blank style='color:#2F92EE;'>#载体#</a>, objectTitle=2021年9月8日简报：国内接种新冠疫苗人数达10.95亿人，超21亿剂次，全国高风险区清零；灭活疫苗接种后采用腺病毒载体疫苗加强，效果可能更好；新冠变异病毒mu毒株覆盖美国全境, objectType=article, longId=216830, objectId=700c216830cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=700c216830cd, replyNumber=0, likeNumber=75, createdTime=2022-08-02, rootId=0, userName=mei539, userId=58cb23213384, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=700c216830cd, moduleTitle=2021年9月8日简报：国内接种新冠疫苗人数达10.95亿人，超21亿剂次，全国高风险区清零；灭活疫苗接种后采用腺病毒载体疫苗加强，效果可能更好；新冠变异病毒mu毒株覆盖美国全境, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=700c216830cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645497, encodeId=ff06164549e0b, content=<a href='/topic/show?id=db329364360' target=_blank style='color:#2F92EE;'>#载体#</a>, objectTitle=研究发现腺病毒载体新冠疫苗诱发血栓的机制, objectType=article, longId=213951, objectId=9a6b21395165, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a6b21395165, replyNumber=0, likeNumber=130, createdTime=2022-02-03, rootId=0, userName=mei539, userId=58cb23213384, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a6b21395165, moduleTitle=研究发现腺病毒载体新冠疫苗诱发血栓的机制, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9a6b21395165)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645495, encodeId=a40a16454959e, content=<a href='/topic/show?id=db329364360' target=_blank style='color:#2F92EE;'>#载体#</a>, objectTitle=强生疫苗或导致血栓，腺病毒载体疫苗还安全吗？, objectType=article, longId=209838, objectId=60f620983808, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60f620983808, replyNumber=0, likeNumber=105, createdTime=2021-08-29, rootId=0, userName=mei539, userId=58cb23213384, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60f620983808, moduleTitle=强生疫苗或导致血栓，腺病毒载体疫苗还安全吗？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=60f620983808)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645504, encodeId=893f164550424, content=<a href='/topic/show?id=db329364360' target=_blank style='color:#2F92EE;'>#载体#</a>, objectTitle=Sci Adv：浙大周民团队用螺旋藻作为药物递送载体，用于结肠癌和结肠炎治疗, objectType=article, longId=221136, objectId=af1722113610, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af1722113610, replyNumber=0, likeNumber=72, createdTime=2022-05-15, rootId=0, userName=mei539, userId=58cb23213384, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af1722113610, moduleTitle=Sci Adv：浙大周民团队用螺旋藻作为药物递送载体，用于结肠癌和结肠炎治疗, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=af1722113610)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645501, encodeId=6885164550137, content=<a href='/topic/show?id=db329364360' target=_blank style='color:#2F92EE;'>#载体#</a>, objectTitle=Nat Nanotech：我国学者开发出高效装载砒霜的仿生递送载体，显著抑制多种白血病, objectType=article, longId=219369, objectId=9a0121936917, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a0121936917, replyNumber=0, likeNumber=0, createdTime=2022-03-27, rootId=0, userName=mei539, userId=58cb23213384, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a0121936917, moduleTitle=Nat Nanotech：我国学者开发出高效装载砒霜的仿生递送载体，显著抑制多种白血病, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9a0121936917)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645503, encodeId=20de164550307, content=<a href='/topic/show?id=db329364360' target=_blank style='color:#2F92EE;'>#载体#</a>, objectTitle=2021年11月13日简报：全球首款吸入式腺病毒载体新冠疫苗克威莎亮相；欧洲多国疫情攀升，北欧多国加强控制, objectType=article, longId=220265, objectId=55d122026515, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55d122026515, replyNumber=0, likeNumber=111, createdTime=2022-03-01, rootId=0, userName=mei539, userId=58cb23213384, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55d122026515, moduleTitle=2021年11月13日简报：全球首款吸入式腺病毒载体新冠疫苗克威莎亮相；欧洲多国疫情攀升，北欧多国加强控制, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=55d122026515)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645496, encodeId=0f55164549608, content=<a href='/topic/show?id=db329364360' target=_blank style='color:#2F92EE;'>#载体#</a>, objectTitle=新冠疫苗前沿知识：mRNA疫苗、重组蛋白疫苗、腺病毒载体疫苗, objectType=article, longId=212051, objectId=95b6212051bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95b6212051bf, replyNumber=0, likeNumber=100, createdTime=2021-08-15, rootId=0, userName=mei539, userId=58cb23213384, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95b6212051bf, moduleTitle=新冠疫苗前沿知识：mRNA疫苗、重组蛋白疫苗、腺病毒载体疫苗, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=95b6212051bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645498, encodeId=4b1816454987b, content=<a href='/topic/show?id=db329364360' target=_blank style='color:#2F92EE;'>#载体#</a>, objectTitle=纳米药物申请新药，将纳米载体和包埋的药物，分别进行申请行吗？, objectType=article, longId=216753, objectId=bfa8216e536d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bfa8216e536d, replyNumber=0, likeNumber=81, createdTime=2022-01-19, rootId=0, userName=mei539, userId=58cb23213384, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bfa8216e536d, moduleTitle=纳米药物申请新药，将纳米载体和包埋的药物，分别进行申请行吗？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=bfa8216e536d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645494, encodeId=63b5164549439, content=<a href='/topic/show?id=db329364360' target=_blank style='color:#2F92EE;'>#载体#</a>, objectTitle=最“安全”基因治疗载体不安全？UniQure宣布基因疗法引发肝癌调查结果, objectType=article, longId=209225, objectId=e64220922508, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e64220922508, replyNumber=0, likeNumber=85, createdTime=2021-05-22, rootId=0, userName=mei539, userId=58cb23213384, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e64220922508, moduleTitle=最“安全”基因治疗载体不安全？UniQure宣布基因疗法引发肝癌调查结果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e64220922508)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1645491, encodeId=aea016454911d, content=<a href='/topic/show?id=db329364360' target=_blank style='color:#2F92EE;'>#载体#</a>, objectTitle=Science：最“安全”基因治疗载体似乎并不安全，血友病患者接受治疗后患上肝癌, objectType=article, longId=204895, objectId=a365204895ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a365204895ab, replyNumber=0, likeNumber=109, createdTime=2021-12-01, rootId=0, userName=mei539, userId=58cb23213384, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a365204895ab, moduleTitle=Science：最“安全”基因治疗载体似乎并不安全，血友病患者接受治疗后患上肝癌, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a365204895ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

载体

2020-05-29

mei539 (审核中...)

前往app查看评论内容

#载体#

Nat Biotech：一次生产10亿CAR-T细胞，新型CRISPR技术，无需病毒载体高效插入超长DNA序列

2023-05-20

mei539 (审核中...)

前往app查看评论内容

#载体#

Arch Dermatol Res：负载维甲酸的纳米脂质载体可有效且安全的治疗寻常痤疮

2022-11-26

mei539 (审核中...)

前往app查看评论内容

#载体#

STTT：治愈乙肝新希望：新型纳米载体，递送siRNA特异性靶向肝细胞

2022-11-16

mei539 (审核中...)

前往app查看评论内容

#载体#

Nature Biomedical Engineering：中科大朱书/王育才团队合作开发新型口服抗生素递送载体，促进吸收，且保护肠道菌群稳态

2022-08-28

mei539 (审核中...)

前往app查看评论内容

#载体#

高效促进吸收！研究开发出新型口服抗生素递送载体

2022-12-22

mei539 (审核中...)

前往app查看评论内容

#载体#

Cell重磅：刘如谦开发新型类病毒载体，安全高效进行体内基因编辑

2022-06-17

mei539 (审核中...)

前往app查看评论内容

#载体#

突发！强生腺病毒载体新冠疫苗因血栓风险，被FDA限制授权使用

2022-06-28

mei539 (审核中...)

前往app查看评论内容

#载体#

秋水仙碱可能会干扰基于腺病毒载体的 COVID-19 疫苗的功效

2022-11-10

mei539 (审核中...)

前往app查看评论内容

#载体#

病毒载体基因治疗CDMO引领者五加和基因完成A轮融资，凯乘资本担任独家财务顾问

2022-01-14

mei539 (审核中...)

前往app查看评论内容

#载体#

HAEMATOLOGICA：离子载体介导的红细胞渗透肿胀是镰状细胞病治疗的潜在机制

2022-03-13

mei539 (审核中...)

前往app查看评论内容

#载体#

2021年9月8日简报：国内接种新冠疫苗人数达10.95亿人，超21亿剂次，全国高风险区清零；灭活疫苗接种后采用腺病毒载体疫苗加强，效果可能更好；新冠变异病毒mu毒株覆盖美国全境

2022-08-02

mei539 (审核中...)

前往app查看评论内容

#载体#

研究发现腺病毒载体新冠疫苗诱发血栓的机制

2022-02-03

mei539 (审核中...)

前往app查看评论内容

#载体#

强生疫苗或导致血栓，腺病毒载体疫苗还安全吗？

2021-08-29

mei539 (审核中...)

前往app查看评论内容

#载体#

Sci Adv：浙大周民团队用螺旋藻作为药物递送载体，用于结肠癌和结肠炎治疗

2022-05-15

mei539 (审核中...)

前往app查看评论内容

#载体#

Nat Nanotech：我国学者开发出高效装载砒霜的仿生递送载体，显著抑制多种白血病

2022-03-27

mei539 (审核中...)

前往app查看评论内容

#载体#

2021年11月13日简报：全球首款吸入式腺病毒载体新冠疫苗克威莎亮相；欧洲多国疫情攀升，北欧多国加强控制

2022-03-01

mei539 (审核中...)

前往app查看评论内容

#载体#

新冠疫苗前沿知识：mRNA疫苗、重组蛋白疫苗、腺病毒载体疫苗

2021-08-15

mei539 (审核中...)

前往app查看评论内容

#载体#

纳米药物申请新药，将纳米载体和包埋的药物，分别进行申请行吗？

2022-01-19

mei539 (审核中...)

前往app查看评论内容

#载体#

最“安全”基因治疗载体不安全？UniQure宣布基因疗法引发肝癌调查结果

2021-05-22

mei539 (审核中...)

前往app查看评论内容

#载体#

Science：最“安全”基因治疗载体似乎并不安全，血友病患者接受治疗后患上肝癌

2021-12-01

科室
- - 订阅+
  - 更多科室
工具
服务